Chinmoyee Das

Title: Chinmoyee Das: Innovator in Pharmacogenetics

Introduction

Chinmoyee Das is a prominent inventor based in New Delhi, India. She has made significant contributions to the field of pharmacogenetics, particularly in understanding the bronchodilatory response to beta agonists. With a total of 2 patents, her work is paving the way for advancements in personalized medicine.

Latest Patents

Chinmoyee Das holds two notable patents. The first patent is titled "Primers for amplifying and detecting the beta 2 adrenergic receptor gene." This invention relates to a method for predicting an individual's bronchodilatory response to a β agonist. It particularly focuses on the detection of specific allelic variants of the β2AR gene and their use as pharmacogenetic markers towards response to β agonists. The second patent, "Method of detecting and predicting bronchodilatory response to beta agonist," also addresses the prediction of an individual's bronchodilatory response to a β agonist, emphasizing the same allelic variants and their pharmacogenetic implications.

Career Highlights

Chinmoyee has worked with esteemed organizations such as the Council of Scientific and Industrial Research and Piramal Life Sciences Limited. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Randeep Guleria and Balram Ghosh. Their collaboration has further enhanced the impact of her research in pharmacogenetics.

Conclusion

Chinmoyee Das is a trailblazer in the field of pharmacogenetics, with her innovative patents contributing to the understanding of individual responses to medication. Her work exemplifies the importance of personalized medicine in improving patient outcomes.